Naomi B. Boekel, MSc, Netherlands Cancer Institute, Amsterdam, Netherlands, discusses DCIS patients' risk of dying from cardiovascular disease.
Naomi B. Boekel, MSc, Netherlands Cancer Institute, Amsterdam, Netherlands, discusses DCIS patients' risk of dying from cardiovascular disease.
A large study in the Netherlands found that women who had received radiation therapy to treat DCIS had no increased risk of cardiovascular disease compared to the general population of Dutch women, nor compared to DCIS patients treated with surgery only.
In addition, researchers found that after a median follow-up of 10 years, DCIS survivors had 30% lower risk of dying from cardiovascular disease compared to the general population of Dutch women.
Boekel theorizes that this could be because DCIS patients adapted their lifestyle after diagnosis, or that there are conflicting risk factors between DCIS and cardiovascular disease (such as age of menopause). Thirdly, there could be a difference in health consciousness between DCIS patients and the general population -- DCIS patients could be generally more health conscious, which is why they went into a screening program and were diagnosed with DCIS, Boekel says.Researchers have several theories about why patients with DCIS had a lower risk of dying from cardiovascular disease:
Batalini Explores Role of UGT1A1 in Patients Treated With Sacituzumab Govitecan for HR+ MBC
April 22nd 2024During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, discussed the TROPiCS-02 trial of sacituzumab govitecan and the impact of the UGT1A1 status on adverse event frequency.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen